| AA | Arachidonic Acid |
| ACC | American College of Cardiology |
| ACS | Acute Coronary Syndrome |
| AGE | Advanced Glycation End products |
| AHA | American Heart Association |
| ASCVD | Atherosclerotic Cardiovascular Disease |
| BMI | Body Mass Index |
| CAD | Coronary Artery Disease |
| CABG | Coronary Artery Bypass Graft |
| CCS | Chronic Coronary Syndrome |
| CETP | Cholesteryl Ester Transfer Protein |
| CI | Confidence Interval |
| CPK-MB | Creatine Kinase-Myocardial brain fraction |
| CV | Cardiovascular |
| CVD | Cardiovascular Disease |
| DES | Drug Eluting Stent |
| EAS | European Atherosclerosis Society |
| eLDL-TG | Estimating Low-Density Lipoprotein-Triglycerides |
| EPA | Eicosapentaenoic Acid |
| ESC | European Society of Cardiology |
| FFAs | Free Fatty Acids |
| FPG | Fasting Plasma Glucose |
| GDMT | Guideline Directed Medical Therapy |
| GISE | Italian Society of Interventional Cardiology |
| HbA1c | Glycated Hemoglobin |
| HDL | High-Density Lipoprotein |
| HeFH | Heterozygous familial hypercholesterolemia |
| HMG Co-A | Hydroxymethylglutaryl-CoA |
| HoFH | Homozygous Familial Hypercholesterolemia |
| HR | Hazard Ratio |
| Hs-CRP | High-sensitivity C-Reactive Protein |
| ICAM-1 | Intercellular Adhesion Molecule-1 |
| IDL | Intermediate-Density Lipoprotein |
| IL | Interleukin |
| IPE | Icosapent Ethyl |
| IQR | Interquartile range |
| IS | Infarct Size |
| IVUS | Intravascular Ultrasound |
| LDE-MTX | Lipid Nanoemulsion-Methotrexate |
| LDL-C | Low-Density Lipoprotein |
| LDL-R | Low-Density Lipoprotein Receptors |
| LLT | Lipid-Lowering Therapy |
| LPL | Lipoprotein Lipase |
| Lp(a) | Lipoprotein A |
| LVR | Left Ventricular Remodeling |
| MACE | Major Adverse Cardiovascular Event |
| MCP | Monocyte Chemotactic Protein |
| MI | Myocardial Infarction |
| MMP | Matrix Metalloproteinases |
| MTX | Methotrexate |
| NADH/NADPH | Nicotinamide adenine dinucleotide reduced form/Nicotinamide adenine dinucleotide phosphate reduced |
| NET | Neutrophil Extracellular Traps |
| NIRS | Near-Infrared Spectroscopy |
| NLRP3 | NACHT, LRR and PYD domains-containing protein 3 |
| NPC1L1 | Niemann-Pick C1-like protein 1 |
| NSTEMI | No-ST-up Elevation Myocardial Infarction |
| NYHA | New York Heart Association |
| OCT | Optical Coherence Tomography |
| OGTT | Oral Glucose Tolerance Test |
| OMT | Optimal Medical Therapy |
| OR | Odds Ratio |
| PAI | Plasma fibrinogen Activator Inhibitor |
| PCI | Percutaneous Coronary Intervention |
| PCSK9-i | Proprotein Convertase Subtilisin/Kexin type 9 Inhibitor |
| PUFA | Polyunsaturated Fatty Acids |
| ROS | Reactive Oxygen Species |
| RR | Relative Risk |
| SIL2r | Soluble IL-2 receptor |
| SMCs | Smooth Muscle Cells |
| STEMI | ST-up Elevation Myocardial Infarction |
| T2DM | Type 2 Diabetes Mellitus |
| TG | Triglycerides |
| TGRLs | Triglyceride-Rich Lipoproteins |
| TNF | Tumor Necrosis Factor |
| TyG | Triglyceride-Glucose |
| VCAM-1 | Vascular Cell Adhesion Molecule-1 |
| VLDL | Very-Low-Density Lipoprotein |